Skip to main content
SpringerLink
Log in

Vorhofflimmern/Vorhofflattern bei speziellen Krankheitsbildern und besonderen Patientengruppen

  • Conference paper
Vorhofflimmern Vorhofflattern

  • 988 Accesses

Auszug

Bei vielen Patienten mit Vorhofflimmern oder Vorhofflattern lässt sich eine kardiale oder extrakardiale Grunderkrankung nachweisen. Die Berücksichtigung der Grunderkrankung hat für die Therapie von Vorhofflimmern und Vorhofflattern besondere Bedeutung. In dieser Übersicht sollen neue Erkenntnisse zu Vorhofflimmern/Vorhofflattern bei folgenden speziellen Krankheitsbildern und Patientengruppen dargestellt werden:

  1. ▮

    bei fortgeschrittener linksventrikulärer Dysfunktion,

  2. ▮

    in der Frühphase nach Herzoperation,

  3. ▮

    bei Patienten mit koronarer Herzerkrankung,

  4. ▮

    bei Patienten mit valvulärer Herzerkrankung,

  5. ▮

    bei Patienten mit hypertensiver und hypertropher Kardiomyopathie,

  6. ▮

    bei Hyperthyreose,

  7. ▮

    bei Vorliegen akzessorischer Leitungsbahnen,

  8. ▮

    bei Vorliegen anhaltender ektoper atrialer Tachykardien,

  9. ▮

    in höherem Lebensalter,

  10. ▮

    bei Leistungssport.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 79.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 99.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. ACC/AHA/ESC Guidelines for the management of patients with atrial fibrillation (2001) Executive summary. Circulation 104:2118–2150

    Google Scholar 

  2. The Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Investigators (2002) A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med 347:1825–1833

    Google Scholar 

  3. The AFFIRM Investigators (2004) Relationships between sinus rhythm, treatment, and survival in the atrial fibrillation follow-up investigation of rhythm management (AFFIRM) study. Circulation 109:1509–1513

    Article  Google Scholar 

  4. Auer J, Weber T, Berent R et al (2004) A comparison between oral anti-arrhythmic drugs in the prevention of atrial fibrillation after cardiac surgery: The pilot study of prevention of postoperative atrial fibrillation (SPPAF), a randomized, placebo-controlled trial. Am Heart J 147:636–643

    Article  PubMed  CAS  Google Scholar 

  5. Benjamin EJ, Levy D, Vaziri SM et al (1994) Independent risk factors for atrial fibrillation in a population-based cohort: the Framingham Heart Study. JAMA 271:840–844

    Article  PubMed  CAS  Google Scholar 

  6. Benussi S, Nascimbene S, Agricola E et al (2002) Surgical ablation of atrial fibrillation using the epicardial radiofrequency approach: mid-term results and risk analysis. Ann Thorac Surg 74:1050–1056

    Article  PubMed  Google Scholar 

  7. Brignole M, Gianfranchi L, Menozzi C et al (1994) Influence of atrioventricular junction radiofrequency ablation in patients with chronic atrial fibrillation and flutter on quality of life and cardiac performance. Am J Cardiol 74: 242–246

    Article  PubMed  CAS  Google Scholar 

  8. Carlsson J, Miketic S, Windeler J et al (2003) Randomized trial of rate-control versus rhythm-control in persistent atrial fibrillation. The strategies of treatment of atrial fibrillation (STAF) study. J Am Coll Cardiol 41:1690–1696

    Article  PubMed  Google Scholar 

  9. Chen MS; McCarthy PM, Lever H et al (2004) Effectiveness of atrial fibrillation surgery in patients with hypertrophic cardiomyopathy. Am J Carddiol 93:373–375

    Article  Google Scholar 

  10. Ciulla MM, Paliotti R, Esposito A et al (2004) Different effects of antihypertensive therapies based on losartan or atenolol on ultrasound and biochemical markers of myocardial fibrosis. Results of a randomized trial. Circula-tion 110:552–557

    Article  CAS  Google Scholar 

  11. Cleland JG, Swedberg K, Follath Fet al for the Study Group on Diagnosis of the Working Group on Heart Failure of the European Society of Cardiology (2003) The EuroHeart Failure survey programme — a survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosis. Eur Heart J 24:442–463

    Article  PubMed  CAS  Google Scholar 

  12. Connolly SJ, Cybulsky I, Lamy A et al (2003) Double-blind, placebo-control-led, randomized trial of prophylactic metoprolol for reduction of hospital length of stay after heart surgery: The beta-Blocker Length of Stay (BLOS) study. Am Heart J 145:226–232

    Article  PubMed  CAS  Google Scholar 

  13. Cox J, Schuessler R, Boineau J (2000) The development of the Maze procedure for the treatment of atrial fibrillation. Semin Thorac Cardiovasc Surg 12:2–14

    Article  PubMed  CAS  Google Scholar 

  14. Crenshaw BS, Ward SR, Granger CB et al (1997) Atrial fibrillation in the setting of acute myocardial infraction: the GUSTO-I experience. Global utilization of streptokinase and TPA for occluded coronary arteries. J Am Car-Cardiol 30:406–413

    Article  CAS  Google Scholar 

  15. Crijns JFGM, Tjeerdsma G, De Kam PF et al (2000) Prognostic value of the presence and development of atrial fibrillation in patients with advanced chronic heart failure. Eur Heart J 21:1238–1245

    Article  PubMed  CAS  Google Scholar 

  16. Crystal E, Healey J, Connolly SJ (2003) Atrial fibrillation after cardiac surgery: update on the evidence on the available prophylactic interventions. Cardiac Electrophysiol Review 7:189–192

    Article  Google Scholar 

  17. Crystal E, Connolly SJ, Sleik K et al (2002) Interventions on prevention of postoperative atrial fibrillation in patients undergoing heart surgery: a meta-analysis. Circulation 106:75–80

    Article  PubMed  Google Scholar 

  18. Daoud EG, Strickberger SA, Man KC et al (1997) Preoperative amiodarone as prophylaxis against atrial fibrillation after heart surgery. N Engl J Med 337: 1785–1791

    Article  PubMed  CAS  Google Scholar 

  19. Daoud EG, Snow R, Hummel JD et al (2003) Temporary atrial epicardial pacing as prophylaxis against atrial fibrillation after heart surgery: a meta-analysis. J Cardiovasc Electrophysiol 14:127–132

    PubMed  Google Scholar 

  20. Devereux RB, Dahlöf B, Gerdts E et al (2004) Regression of hypertensive left ventricular hypertrphy by losartan compared with atenolol The Losartan intervention for endpoint reduction in hypertension (LIFE) trial. Circulation 110:1456–1462

    Article  PubMed  CAS  Google Scholar 

  21. Dreifus LS; Haiat R, Watanabe Y et al (1971) Ventricular fibrillation. A possible mechanism of sudden death in patients with Wolff-Parkinson-White syndrome. Circulation 43:520–527

    PubMed  CAS  Google Scholar 

  22. Favale S, Pappone C, Nacci F et al (2003) Sudden death due to atrial fibrillation in hypertrophic cardiomyopathy: a predictable event in a young patient. PACE 26 (pt.I):637–639

    PubMed  Google Scholar 

  23. Feinberg WM, Blackshear JL, Laupacis A et al (1995) Prevalence, age, distribution and gender of patients with atrial fibrillation. Analysis and implications. Arch Intern Med 155:469–473

    Article  PubMed  CAS  Google Scholar 

  24. Fuller JA, Adams GG, Buxton B (1989) Atrial fibrillation after coronary artery bypass grafting. Is it a disorder of the elderly?. J Thorac Cardiovasc Surg 97: 821–825

    PubMed  CAS  Google Scholar 

  25. Goldman L (1978) Supraventricular tachyarrhythmias in hospitalized adults after surgery. Clinicial correlates in patients over 40 years of age after major noncardiac surgery. Chest 73:450–454

    PubMed  CAS  Google Scholar 

  26. Haissaguerre M, Fischer B, Labbe T et al (1992) Frequency of recurrent atrial fibrillation after catheter ablation of overt accessory pathways. Am J Cardiol 69:493–497

    Article  PubMed  CAS  Google Scholar 

  27. Handa N, Schaff HV, Morris JJ et al (1999) Outcome of valve repair and the Cox Maze procedure for mitral regurgitation and associated atrial fibrillation. J Thorac Cardiovasc Surg 118:628–635

    Article  PubMed  CAS  Google Scholar 

  28. Hohnloser SH, Kuck KH, Lilienthal J, for the PIAF Investigators (2000) Rhythm or rate control in atrial fibrillation — pharmacological intervention in atrial fibrillation (PIAF): a randomised trial. Lancet 356:1789–1794

    Article  PubMed  CAS  Google Scholar 

  29. Hoogsteen J, Schep G, Van Hemel NM et al (2004) Paroxysmal atrial fibrillation in male endurance athletes. A 9-year follow up. Europace 6:222–228

    Article  PubMed  Google Scholar 

  30. Hsu LF, Jais P, Sanders P et al (2004) Catheter ablation for atrial fibrillation in congestive heart failure. N Engl J Med 351:2373–2383

    Article  PubMed  CAS  Google Scholar 

  31. Kannel WB, Wolf PA, Benjamin EJ et al (1998) Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates. Am J Cardiol 82(8A):2N–9N

    Article  PubMed  CAS  Google Scholar 

  32. Khargi K, Deneke T, Haardt H et al (2001) Saline-irrigated cooled-tip radiofrequency ablation is an effective technique to perform the maze procedure. Ann Thorac Surg 72(Suppl): 1090–1095

    Article  Google Scholar 

  33. Klein GJ, Bashore TM, Sellers TD et al (1979) Ventricular fibrillation in the Wolff-Parkinson-White syndrome. N Engl J Med 301:1080–1085

    PubMed  CAS  Google Scholar 

  34. Kuck KH, Kunze KP, Schlüter M et al (1988) Programmed electrical stimulation in hypertrophic cardiomyopathy. Results in patients with and without cardiac arrest or syncope. Eur Heart J 9:177–185

    PubMed  CAS  Google Scholar 

  35. Lang C, Santinelli V, Augello G (2005) Transcatheter radiofrequency ablation of atrial fibrillation in patients with mitral valve prostheses and enlarged atria. Safety, feasibility, and efficacy. J Am Coll Cardiol 45:868–872

    Article  PubMed  Google Scholar 

  36. Lewalter T, Lüderitz B (2005) Vorhofflimmern — Interventionelle Differential-therapie unter besonderer Berücksichtigung des Lebensalters. Dtsch Med Wochenschr 130:721–725

    Article  PubMed  Google Scholar 

  37. Losi MA, Betocchi S, Aversa M et al (2004) Determinants of atrial fibrillation development in patients with hypertrophic cardiomyopathy. Am J Cardiol 94:895–900

    Article  PubMed  Google Scholar 

  38. Madrid AH, Bueno MG, Rebollo JMG et al (2002) Use of irbesartan to maintain sinus rhythm in patients with long-lasting persistent atrial fibrillation. A prospective and randomized study. Circulation 106:331–336

    Article  PubMed  CAS  Google Scholar 

  39. Mathew J, Hunsberger S, Fleg J et al, for the Digitalis Investigation Group (2000) Incidence, predictive factors, and prognostic significance of supraventricular tachyarrhythmias in congestive heart failure. Chest 118:914–922

    Article  PubMed  CAS  Google Scholar 

  40. Middlekauff HR, Stevenson WG, Stevenson LW (1991) Prognostic significance of atrial fibrillation in advanced heart failure. A study of 390 patients. Circulation 84:40–48

    PubMed  CAS  Google Scholar 

  41. Mont L, Sambola A, Brugada J et al (2002) Long-lasting sport practice and lone atrial fibrillation. Eur Heart J 23:477–482

    Article  PubMed  CAS  Google Scholar 

  42. Nakazawa HK, Sakurai K, Hamada N et al (1982) Management of atrial fibrillation in the post-thyrotoxic state. Am J Med 72:903–906

    Article  PubMed  CAS  Google Scholar 

  43. Pappone C, Santinelli V, Manguso F et al (2003) A randomized study of prophylactic catheter ablation in asymptomatic patients with the Wolff-Parkinson-White syndrome. N Engl J Med 349:1803–1811

    Article  PubMed  CAS  Google Scholar 

  44. Pappone C, Santinelli V, Rosanio S et al (2003) Usefulness of invasive electro-physiologic testing to stratify the risk of arrhythmic events in asymptomatic patients with Wolff-Parkinson-White pattern: results from a large prospective long-term follow-up study. J Am Coll Cardiol 41:239–244

    Article  PubMed  Google Scholar 

  45. Pappone C, Rosanio S, Augello G et al (2004) Mortality, morbidity, and quality of life after circumferential pulmonary vein ablation for atrial fibrillation: outcomes from a controlled nonrandomized long-term study. J Am Coll Cardiol 42:185–197

    Article  Google Scholar 

  46. Prasad SM, Maniar HS, Camillo CJ et al (2003) The Cox Maze III procedure for atrial fibrillation: long term efficacy in patients undergoing lone versus concomitant procedures. J Thorac Cardiovasc Surg 126:1822–1828

    Article  PubMed  Google Scholar 

  47. Rahimtoola SH, Ehsani A, Sinno MZ et al (1975) Left atrial transport function in myocardial infarction. Importance of its booster pump function. Am J Med 59:686–694

    Article  PubMed  CAS  Google Scholar 

  48. Reithmann C, Dorwarth U, Fiek M et al (2005) Outcome of ablation for sustained focal atrial tachycardia in patients with and without a history of atrial fibrillation. J Intervent Card Electrophysiol 12:35–43

    Article  Google Scholar 

  49. Rost R (1998) Der interessante sportmedizinische Fall. Deutsche Zeitschrift für Sportmedizin 49:313

    Google Scholar 

  50. Savelieva I, Camm JA (2004) Atrial fibrillation and heart failure: natural history and pharmacological treatment. Europace 5: S5–S19

    Article  PubMed  Google Scholar 

  51. Sharma AD, Yee R, Guiraudon G et al (1987) Sensitivity and specificity of invasive and noninvasive testing for risk of sudden death in Wolff-Parkinson-White syndrome. J Am Coll Cardiol 10:373–381

    PubMed  CAS  Google Scholar 

  52. Sie H, Beukema W, Elvan A et al (2004) Long-term results of irrigated radio-frequency modified Maze procedure in 200 patients with concomitant cardiac surgery: six years experience. Ann Thorac Surg 77:512–517

    Article  PubMed  Google Scholar 

  53. Skoularigis J, Röthlisberger C, Skudicky D et al (1993) Effectiveness of amio-darone and electrical cardioversion for chronic rheumatic atrial fibrillation after mitral valve surgery. Am J Cardiol 72:423–427

    Article  PubMed  CAS  Google Scholar 

  54. Staffurth JS, Gibberd MC, Fui ST (1977) Arterial embolism in thyrotoxicosis with atrial fibrillation. Br Med J 2:688–690

    PubMed  CAS  Google Scholar 

  55. Stevenson WG, Stevenson LW (2004) Atrial fibrillation and heart failure — five more years. N Engl M Med 351:2437–2440

    Article  CAS  Google Scholar 

  56. Sung RJ, Castellanos A, Mallon SM et al (1977) Mechanisms of spontaneous alternation between reciprocating tachycardia and atrial flutter-fibrillation in the Wolff-Parkinson-White syndrome. Circulation 56:409–416

    PubMed  CAS  Google Scholar 

  57. Suzuki M, Hirayama T, Marumoto K et al (1998) Paroxysmal atrial fibrillation as a cause of potentially lethal ventricular arrhythmia with myocardial ischemia in hypertrophic cardiomyopathy — a case report. Angiology 49:653–657

    PubMed  CAS  Google Scholar 

  58. Torner Montoya P, Brugada P, Smeets J et al Ventricular fibrillation in the Wolff-Parkinson-White syndrome. Eur Heart J 12:144–150

    Google Scholar 

  59. Tsang TS, Gersh BJ, Appleton CP et al (2002) Left ventricular diastolic dysfunction as a predictor of the first diagnosed nonvalvular atrial fibrillation in 840 elderly men and women. J Am Coll Cardiol 40:1636–1644

    Article  PubMed  Google Scholar 

  60. Van Gelder IC, Hagens VE, Bosker HA et al (2002) A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation. N Engl J Med 347:1834–1840

    Article  PubMed  Google Scholar 

  61. Wachtell K, Lehto M, Gerdts E et al (2005) Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol. The Losartan Intervention for End Point Reduction in Hypertension (LIFE) Study. J Am Coll Cardiol 45:712–719

    Article  PubMed  CAS  Google Scholar 

  62. Wachtell K, Hornestam B, Lehto M et al (2005) Cardiovascular morbidity and mortality in hypertensive patients with a history of atrial fibrillation. The Losaraen Intervention for End Point Reduction in Hypertension (LIFE) Study. J Am Coll Cardiol 45:705–711

    Article  PubMed  Google Scholar 

  63. Wang TJ, Larson MG, Levy D (2003) Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality. The Fra-mingham Heart study. Circulation 107:2920–2925

    Article  PubMed  Google Scholar 

  64. Waspe LE, Brodman R, Kim SG et al (1986) Susceptibility to atrial fibrillation and ventricular tachyarrhythmia in the Wolff-Parkinson-White syndrome: role of the accessory pathway. Am Heart J 112:1141–1152

    Article  PubMed  CAS  Google Scholar 

  65. Williams MR, Stewart JR, Boiling SF et al (2001) Surgical treatment of atrial fibrillation using radiofrequency energy. Ann Thorac Surg 71:1939–1944

    Article  PubMed  CAS  Google Scholar 

  66. White CM, Giri S, Tsikouris JP et al (2002) A comparison of two individual amiodarone regimens to placebo in open heart surgery patients. Ann Thorac Surg 74:69–74

    Article  PubMed  Google Scholar 

  67. Young-Xu Y, Jabbour S, Goldberg R et al (2003) Usefulness of statin drugs in protecting against atrial fibrillation in patients with coronary artery disease. Am J Cardiol 92:1379–1383

    Article  PubMed  CAS  Google Scholar 

  68. Yuda S, Nakatani S, Kosakai Y et al (2001) Long-term follow-up of atrial contraction after the maze procedure in patients with mitral valve disease. J Am Coll Cardiol 37:1622–1627

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. I. Med. Klinik, Klinikum Großhadern, Marchioninstraße 15, 81377, München

    Priv.-Doz. Dr. med. C. Reithmann

  2. Abt. für Kardiologie u. Pneumologie, Städt. Krankenhaus München-Bogenhausen, Englschalkinger Straße 77, 81925, München

    Prof. Dr. med. E. Hoffmann

Authors
  1. Priv.-Doz. Dr. med. C. Reithmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Prof. Dr. med. E. Hoffmann
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Medizinische Klinik II, Klinikum Kassel, Möncheberg Straße 41-43, 34125, Kassel

    Jörg Neuzner

  2. Kerkhoff-Klinik Abt. für Kardiologie, Benekestraße 2-8, 61231, Bad Nauheim

    Heinz F. Pitschner

Rights and permissions

Reprints and permissions

Copyright information

© 2007 Steinkopff Verlag Darmstadt

About this paper

Cite this paper

Reithmann, C., Hoffmann, E. (2007). Vorhofflimmern/Vorhofflattern bei speziellen Krankheitsbildern und besonderen Patientengruppen. In: Neuzner, J., Pitschner, H.F. (eds) Vorhofflimmern Vorhofflattern. Steinkopff. https://doi.org/10.1007/978-3-7985-1748-6_19

Download citation

  • DOI: https://doi.org/10.1007/978-3-7985-1748-6_19

  • Publisher Name: Steinkopff

  • Print ISBN: 978-3-7985-1506-2

  • Online ISBN: 978-3-7985-1748-6

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation